Drugs & Targets Alecensa gets FDA approval for ALK-positive metastatic NSCLC November 10, 2017Vol.43 No.42
Drugs & Targets FDA approves first treatment for Erdheim-Chester Disease November 10, 2017Vol.43 No.42
Drugs & Targets FDA approves Adcetris for cutaneous anaplastic large cell lymphoma November 10, 2017Vol.43 No.42
Drugs & Targets Seattle Genetics submits sBLA for Adcetris in Hodgkin lymphoma November 10, 2017Vol.43 No.42
In Brief Hopkins researchers launch interdisciplinary effort for breast cancer November 10, 2017Vol.43 No.42
In Brief Neuroblastoma foundation awards grant to Harvard’s Malgorzata Krajewska November 10, 2017Vol.43 No.42
